بدائل البحث:
marker increase » marked increases (توسيع البحث), larger increases (توسيع البحث), marked decrease (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
e decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), _ decreased (توسيع البحث)
n marked » _ marked (توسيع البحث), a marked (توسيع البحث), _ market (توسيع البحث)
a marker » _ marker (توسيع البحث), _ markers (توسيع البحث)
marker increase » marked increases (توسيع البحث), larger increases (توسيع البحث), marked decrease (توسيع البحث)
mean decrease » a decrease (توسيع البحث)
e decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), _ decreased (توسيع البحث)
n marked » _ marked (توسيع البحث), a marked (توسيع البحث), _ market (توسيع البحث)
a marker » _ marker (توسيع البحث), _ markers (توسيع البحث)
-
1
Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling.
منشور في 2021"…<p>Immunohistochemical analysis of six-week-old control and <i>Ubr5</i><sup><i>mt</i></sup> tibial AC examined for markers of canonical HH pathway activity. Relative to (A, C) control, (B, D) <i>Ubr5</i><sup><i>mt</i></sup> AC displayed increased staining intensities for PTCH1 (A, B) and GLI1 (C, D) with GLI1 exhibiting expanded expression domains (D, double-headed arrows). …"
-
2
-
3
-
4
Regenerating axons are increased by ATRA and decreased by clodronate.
منشور في 2021"…<p>(A—E) Confocal images of immunohistochemical staining of growing axons with anti-GAP43 antibody (green), in longitudinal sections of the optic nerve at 2 weeks after axotomy. …"
-
5
Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1.
منشور في 2021"…(C) Decrease in ISC markers, OLFM4 and SOX9 in <i>Mll1</i><sup><i>FC/FC; Vil-Cre-ERT2/+</i></sup> intestinal sections. …"
-
6
The subacute phase (one week after stroke) is characterized by an increase of the event duration and decrease of smoothness.
منشور في 2021"…<p>During the subacute phase, <b>(A-B)</b> the event duration is increased, <b>(C-D)</b> smoothness is decreased, and <b>(E-F)</b> the direction of propagation is more spread.…"
-
7
-
8
-
9
-
10
-
11
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…<p>(A) Representative images showed calcium deposition (red). (B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20